Dimethazan
In the world of Dimethazan, there is a wide range of opinions and perspectives that can be approached from different angles. From its impact on society to its relevance in history, Dimethazan has been the subject of study and controversy over time. In this article, we will explore the various facets of Dimethazan, analyzing its influence in different contexts and its role in everyday life. Additionally, we will examine how Dimethazan has evolved over time and what the future holds for it in an increasingly changing world. Through this exhaustive analysis, we aim to shed light on a topic that remains relevant and exciting to a wide spectrum of people.
 | |
 | |
| Clinical data | |
|---|---|
| Other names | 1,3-dimethyl-7-(2-dimethylaminoethyl)xanthine; 7-(2-dimethylaminoethyl)theophylline |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.516 |
| Chemical and physical data | |
| Formula | C11H17N5O2 |
| Molar mass | 251.290 g·mol−1 |
| 3D model (JSmol) | |
| |
Dimethazan (Elidin) is a stimulant drug of the xanthine class related to caffeine and theophylline.[1] It also has tranquilizing and respiratory-stimulating effects and has been sold as an antidepressant.[1][2]
See also
References
- ^ a b BATTERMAN RC, GROSSMAN AJ, LEIFER P, MOURATOFF GJ (August 1958). "Central nervous system stimulation and sedation with dimethazan". The American Journal of the Medical Sciences. 236 (2): 162–7. doi:10.1097/00000441-195808000-00005. PMID 13559232. S2CID 26657520.
- ^ O'Neil, Maryadele J. (2001). The Merck index: an encyclopedia of chemicals, drugs, and biologicals. Rahway, NJ: Merck Research Laboratories. ISBN 0-911910-13-1.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |